Drafting of comprehensive harmonized regulatory guideline for storage and disposal of radiopharmaceuticals
Recent era has witnessed an inordinate rise in the demand for radiopharmaceuticals due to their multifarious biomedical and clinical application. Scientific fraternity worldwide is continuously working in developing different innovative radiopharmaceuticals of immense clinical importance both from specialized theranostics and personalized medicine point of view. However, this increased production and use of radiopharmaceuticals in various nuclear medicine procedures have been accompanied by an inevitable problem concerning their storage after use and final disposal. Keeping in view the inherently hazardous nature of radiopharmaceuticals due to the presence of radionuclide in them, it is imperative to have an adequate regulatory backup which if followed meticulously can assure their safe storage and disposal so that threat to men and environment is prevented. The present work has been aimed to draft comprehensive regulatory guidelines for the storage and disposal of radiopharmaceuticals which is in resonance with the global standards. For this, the methodology consisting of a thorough research of existing guidelines from Atomic Energy Regulatory Board (AERB) exclusively on storage and disposal of radiopharmaceuticals in India has been done with the objective to identify and select various parameters not yet explicitly covered as is their scope. The guideline has been made to suitably address all sorts of necessary documentation, allocation of responsibility, ways of waste prevention, various mechanisms to deal with radiopharmaceuticals waste in all forms of matter and suggestive recommendations.
Keywords: Radiopharmaceuticals, Atomic Energy Regulatory Board, Regulatory guidelines of radiopharmaceuticals
2. Volkert, WA, Goeckeler WF, Ehrhardt GJ, Ketring AR, Therapeutic radionuclides: production and decay property considerations, Journal of Nuclear Medicine, 1991; 32:174-185.
3. Saha GB, Production of Radionuclides. In: fundamentals of Nuclear Pharmacy. New York, Springer, 1984.
4. Ballinger JR, Theranostic radiopharmaceuticals: established agents in current use, The British Journal of Radiology, 2018; 91(1091).
5. Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M, Theranostics in nuclear medicine practice, OncoTargets and Therapy, 2017; 10:4821–4828.
6. National Research Council (US) Committee on Prudent Practices in the Laboratory, Washington (DC): National Academies Press (US); 2011
7. Lange R, Heine RT, Decristoforo C, Penuelas I, Elsinga PH, Westerlaken ML, Hendrikse NH, Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals, Nuclear Medicine Communications, 2015; 36(5):414-422.
8. Atomic Energy (Safe Disposal of Radioactive Wastes) Rules, G.S.R 125. Atomic Energy Regulatory Board, 1987
9. Management of Radioactive Waste, CODE NO.AERB/NRF/ SC/RW, Atomic Energy Regulatory Board, 2007.
10. Nuclear Medicine Facilities, CODE NO. AERB/RF-MED/SC-2 (Rev. 2), Atomic Energy Regulatory Board, 2010.
11. Ennow K, Waste Disposal. In: Kristensen K., Nørbygaard E. (eds) Safety and Efficacy of Radiopharmaceuticals. Developments in Nuclear Medicine, Springer, Dordrecht, 14; 1987.
12. Rodríguez JC, Biochroma – A New and Patented Technology for Processing Radioactive Wastewater from Nuclear Medicine Therapy Facilities in Hospitals and Clinics, Journal of Nuclear Medicine & Radiation Therapy, 2011; 2(3):1-6.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).